These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8904473)

  • 1. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
    Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M
    J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose intravenous immunoglobulin therapy in the treatment of rhesus hemolytic disease.
    Aggarwal R; Seth R; Paul VK; Deorari AK
    J Trop Pediatr; 2002 Apr; 48(2):116-7. PubMed ID: 12022426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins in rhesus hemolytic disease.
    Mukhopadhyay K; Murki S; Narang A; Dutta S
    Indian J Pediatr; 2003 Sep; 70(9):697-9. PubMed ID: 14620183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
    Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
    Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility].
    Rübo J; Wahn V
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():104-8; discussion 109. PubMed ID: 8499737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
    Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Rh-Hemolytic Disease in Neonates and Management with Early Intensive Phototherapy in the Neonatal Intensive Care Unit.
    Tewari VV; Kumar A; Singhal A; Pillai N; Prakash A; Varghese J; Kannan V
    J Trop Pediatr; 2020 Feb; 66(1):75-84. PubMed ID: 31199484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous IgG for the treatment of severe rhesus alloimmunization.
    Margulies M; Voto LS; Mathet E; Margulies M
    Vox Sang; 1991; 61(3):181-9. PubMed ID: 1807059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
    Alpay F; Sarici SU; Okutan V; Erdem G; Ozcan O; Gökçay E
    Acta Paediatr; 1999 Feb; 88(2):216-9. PubMed ID: 10102158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease.
    Alonso JG; Decaro J; Marrero A; Lavalle E; Martell M; Cuadro JC
    J Perinat Med; 1994; 22(5):415-9. PubMed ID: 7791017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.